Drug intelligence / Profile preview

yangzheng xiaoji capsule

Development stage
Phase 4
Lead developer
Yiling Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Yangzheng Xiaoji Capsule is a traditional Chinese medicine (TCM) formulation developed for use as an adjuvant therapy in cancer treatment, particularly for primary liver cancer in patients unsuitable for surgery due to dual deficiency of the spleen and kidney with internal obstruction of stasis toxin. The capsule contains a blend of herbal ingredients including Astragalus Root, Glossy Privet Fruit, Ginseng, Zedoaria, Lucid Ganoderma (Reishi), Fiveleaf Gynostemma, Roasted Rhizoma Atractylodis Macrocephalae, Barbated Skullcap Herb, Spreading Hedyotis Herb, Poria Slices, Ground Beetle (Eupolyphaga), Chicken's Gizzard-membrane (Endothelium Corneum Gigeriae Galli), Indian mockstrawberry herb (Duchesnea indica), Bittersweet Herb (Solanum nigrum), Capillary Wormwood Herb (Artemisia capillaris), and Paniculate Swallowwort Root. \nThe mechanism of action is multi-faceted and includes fortifying the spleen and kidney function according to TCM theory; inhibiting tumor angiogenesis; suppressing tumor metastasis; modulating immune response; reducing toxicity from chemotherapy/radiotherapy on white blood cells and liver function; improving quality of life by alleviating symptoms such as poor appetite and fatigue. Clinical studies suggest it can reduce adverse effects associated with conventional cancer therapies[3][5][6][8]. \nYangzheng Xiaoji Capsule has been studied internationally—including research collaborations between Cardiff University in the UK and Yiling Pharmaceutical—demonstrating its potential to inhibit tumor metastasis[6].

Brand names
Yangzheng Xiaoji Capsule
Other names
养正消积胶囊yangzheng xiaoji jiaonangYZXJ extract
02

Targets

FAK (Focal adhesion kinase)

Beyond the preview

Go deeper on yangzheng xiaoji capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yangzheng xiaoji capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call